CSF1R and Alzheimer disease: The modulation of microglia proliferation and survival by targeting CSF1R not only demonstrates the essential role of these cells in pre-pathological stages of AD but also proves that eliminating “senescent” microglia or stimulating the proliferation of new homeostatic microglia may be a feasible strategy to prevent AD pathology.